§ 25 Assisted Reproductive Technology (Regulation) Act, 2021

LawFinder — Section Detail

Section 25. Preimplantation Genetic Diagnosis

Review the original statutory text or switch to the plain-language version. Related sections and acts remain accessible without interrupting your research flow.

Act
Assisted Reproductive Technology (Regulation) Act, 2021
Section number
25

Section reader


The Assisted Reproductive Technology (Regulation) Act, 2021

25. Preimplantation Genetic Diagnosis. -

(1) The Pre-implantation Genetic testing shall be used to screen the human embryo for known, pre-existing, heritable or genetic diseases only.

(2) The donation of an embryo after Pre-implantation Genetic Diagnosis to an approved research laboratory for research purposes shall be done only-

(a) with the approval of the commissioning couple or woman; and

(b) when the embryo suffers from pre-existing, heritable, life-threatening or genetic diseases.

(3) The National Board may lay down such other conditions as it deems fit in the interests of the Pre-implantation Genetic testing.

Explanation.-For the purposes of this section, the expression-

(i) "Pre-implantation Genetic Diagnosis" means the genetic diagnosis when one or both genetic parents has a known genetic abnormality and testing is performed on an embryo to determine if it also carries a genetic abnormality; and

(ii) "Pre-implantation Genetic testing" means a technique used to identify genetic defects in embryos created through in-vitro fertilisation before pregnancy.